Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Letrine 2.5mg Tablet

Prescription Icon
Prescription Required

Marketer

Rhine Biogenics Pvt Ltd

Salt Composition

Letrozole (2.5mg)

Overview Letrine 2.5mg Tablet

Postmenopausal women with breast cancer may find relief with Letrine 2.5mg Tablets. This medication can be administered independently or alongside other therapies like surgery or radiotherapy. In advanced cases, it aids in preventing metastasis. Letrine 2.5mg Tablets can be ingested with or without food, always following your physician's prescribed dosage and duration for optimal results. Dosage frequency varies depending on the treatment goal; your doctor will tailor the regimen to manage your symptoms effectively. Continue the medication as directed. Common side effects include sweating, tiredness, hot flushes, and elevated cholesterol. Report any concerning side effects to your doctor, who can offer management strategies. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, osteoporosis, or other medications you're currently using, as interactions may occur. Disclose pregnancy or breastfeeding status to your physician. Pre- and ongoing blood tests may be conducted to monitor vitamin D levels and bone density.

Uses of Letrine 2.5mg Tablet

Managing breast cancer

Major Benefits of Letrine 2.5mg Tablet:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Letrine 2.5mg Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Letrine 2.5mg Tablet:

  • Dizziness
  • Fatigue
  • Weakness
  • Bone pain
  • Back pain
  • Night sweats
  • Joint pain
  • Nausea
  • Osteoporosis
  • Joint inflammation
  • Weight gain
  • Hot flushes
  • Edema (swelling)
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Diaphoresis
  • Bone fracture
  • Hypercholesterolemia (high cholesterol)
  • Cough
  • Shortness of breath

How to use Letrine 2.5mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Letrine 2.5mg Tablets can be consumed with or without food, although consistent timing is recommended.

How Letrine 2.5mg Tablet works:

Estrogen production is reduced by the aromatase inhibitor Letrine 2.5mg Tablet. This lowered estrogen level can inhibit or halt the progression of certain estrogen-dependent breast cancers.

SAFETY ADVICE

AlcoholAlcoholSAFE

Letrine 2.5mg Tablet consumption alongside alcohol poses no known adverse reactions.

PregnancyPregnancyUNSAFE

Administering Letrine 2.5mg tablets to pregnant individuals poses a substantial risk. Pregnant women should consult their physician before use; research in animal and human studies indicates considerable potential harm to the fetus.

Breast feedingBreast feedingUNSAFE

The use of Letrine 2.5mg tablets while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates the medication may harm the nursing infant.

DrivingDrivingUNSAFE

Taking a 2.5mg Letrine tablet might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

The use of Letrine 2.5mg tablets is considered safe for individuals with kidney impairment; no dosage modification is necessary. Data regarding its use in patients with end-stage renal disease is, however, scarce. Physician consultation is advised.

LiverLiverCAUTION

Exercise caution when administering Letrine 2.5mg Tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Letrine 2.5mg Tablet :

Should you forget a Letrine 2.5mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Letrine 2.5mg Tablet

LabelValue
Chemical Category Diphenylmethane-based compound
Developing Habits No.
Treatment Category Cancer Medications

FAQs on Letrine 2.5mg Tablet

Letrine 2.5mg tablets are aromatase inhibitors used to treat breast cancer in postmenopausal women.
Letrine 2.5mg tablets are anti-estrogens. They work by inhibiting aromatase, the enzyme that produces estrogen, thereby lowering estrogen levels. This is beneficial because estrogen fuels the growth of certain breast cancers, known as estrogen-dependent cancers. Lowering estrogen levels can therefore help prevent cancer growth.
For advanced breast cancer or cancer that has spread, continue Letrine 2.5mg Tablet until tumor progression. Following tamoxifen or surgery, take Letrine 2.5mg Tablet for five years, or until recurrence, whichever occurs first. Alternatively, a sequential treatment of two years of Letrine 2.5mg Tablet followed by three years of tamoxifen may be used.
While irbesartan and Letrine 2.5mg Tablet can be taken together, monitor your blood pressure closely as Letrine 2.5mg Tablet may elevate it. Consult your doctor if blood pressure management becomes difficult.
While rare, Letrine 2.5mg tablets may cause cataracts. Seek immediate medical attention if you develop blurred vision or eye irritation.
Letrine 2.5mg Tablets may cause hot flushes, a common side effect resulting from decreased estrogen. These typically lessen as your body adapts, but may persist throughout treatment and subside afterward. If hot flushes are severe, consult your doctor for management options.
Letrine 2.5mg Tablet may rarely cause serious side effects, including stroke, angina, heart attack, blood clots, cataracts, osteoporosis, and severe skin reactions.
Letrine 2.5mg Tablets can reduce bone density (osteoporosis) by lowering estrogen levels. Your doctor may monitor your bone density with tests before, during, and after treatment.
The Ministry of Health and Family Welfare restricts Letrine 2.5mg Tablets to use only in inducing ovulation for women with anovulatory infertility.
Letrine 2.5mg Tablet
177